Franklin R. Witney
Independent Non-Employee DirectorDr. Franklin R. Witney, also known as Frank, Ph.D., is Independent Director of Alamar Biosciences, Inc. from January 2026 and serves as its Lead Independent Director since April 2026. He also known as Frank, served as a Director of Telesis Bio, Inc. since December 2020 and served as its Independent Chairman of the Board until August 27, 2024. He serves on the Board of BioEcho Life Sciences GmbH. He serves as has been an Independent Director of Revvity, Inc. since July 27, 2016. He serves as Independent Non-Employee Director of Standard BioTools Inc. since April 05, 2022. He has been Operating Partner at Ampersand Management LLC(Formerly know as Ampersand Capital Partners_ since joining the firm in 2016. Dr. Witney served as the Chief Executive Officer and President at Affymetrix Inc., from July 2011 to March 2016. He served as the President and Chief Executive Officer of Dionex Corporation, from April 2009 to May 2011. He served as the President of Packard Instrument Company Inc. since October 2000. He was responsible for its global operations, including research and development, manufacturing, marketing and worldwide sales. He served as Senior Vice President of Packard Instrument Company Inc. since April 2000. He previously held the role of President of PerkinElmers Drug Discovery Tools division following PerkinElmers acquisition of Packard BioScience in 2001, where he served as President and Chief Operating Officer. He was responsible for the development and execution of the strategic plan and the performance of Packard Instrument Company, CCS Packard Inc., Packard BioScience B.V., BioSignal Packard, Inc. and Packard Bioscience Co.'s international sales subsidiaries. He served as the President and Chief Executive Officer of Panomics Inc. from July 2002 to December 2008. Dr. Witney served as Chairman at Canopy Biosciences, LLC. He served as Director at Nexcelom Biosciences LLC and serves as an active Board Observer of GenDx. He served as Executive Director of GenapSys, Inc. He served as the President and Chief Executive Officer of Revvity, Inc. He has experience in leadership and innovation in the life science industry. His professional and academic interests have been focused on the biotech and life sciences market throughout his career. He has a tremendous reputation in the life sciences marketplace and as a successful biotech entrepreneur. He has a detailed understanding of genomics and gene regulation for drug targeting and therapeutic research. He served as the Chief Commercial Officer and Executive Vice President of Affymetrix, Inc. from December 2008 to April 10, 2009. He served as President of Drug Discovery Tools division of PerkinElmer Life Sciences, Inc., from November 2001 to July 2002. He is Operating Partner at Ampersand Capital Partners. He was responsible for the reagent and instrument businesses that included high-throughput screening, research products, genomics and proteomics and liquid handling automation at PerkinElmer Life Sciences. He served as the President and Chief Operating Officer of Packard BioScience Company from October 2000 to November 2001. From 1983 to 2000, he held a series of management positions at Bio-Rad Laboratories beginning in 1983, where he served as Group Operations Manager of Life Sciences from July 1997 to April 2000. He was the Chairman of Gyros Protein Technologies AB since June 22, 2016. Dr. Witney served as the Chairman of the Board at Exagen Diagnostics, Inc. since July 2015. He had been an Independent Director of Cerus Corporation since March 2014 until June 20, 2025 and serves as its Lead Independent Director since June 20, 2025. He served as a Director of Genoptix, Inc. He served as a Director of Emulate, Inc until 2024. He served as Director of RareCyte, Inc. since August 2016 until October 2020. He serves as Chairman at Biologos, LLC. He serves as Director of PerkinElmer LAS (Germany) GmbH. He serves as a Director of One Lambda, Inc. and GenapSys, Inc. He serves on the Board of JumpCode Genomics, Inc. since January 12, 2021. He served as an Independent Director of Exagen Diagnostics, Inc. since September 18, 2014. He served as a Director of Fluidigm Sciences, Inc, GeneOptx and Canopy Biosciences, LLC. He served as a Director of DVS Sciences Inc. He served as Director of Panomics, Inc. He served as Director of Dionex Corp. from April 30, 2009 to May 17, 2011. He served as a Director of Applied Precision Inc. since December 2005. Dr. Witney has served as Director of Affymetrix, Inc. from July 2011 to March 31, 2016. He served as Director of Transgenomic Inc. from April 18, 2007 to May 20, 2009. He has a long and distinguished career in the laboratory products sector. He has authored more than 15 papers on molecular biology and biochemistry and holds seven patents. Dr. Witney serves as Director of Leinco Technologies, Inc. He was a post-doctoral fellow at the National Institutes of Health from 1980 to 1983. Dr. Witney holds a B.S. in Microbiology from the University of Illinois and an M.S. in Microbiology and a doctorate (Ph.D.) in Molecular and Cellular Biology from Indiana University.
公司職務
- 公司名稱Standard BioTools Inc.股票代碼LAB職務Independent Non-Employee Director共事同僚
- MEMichael EgholmPresident, CEO & Director
- TDThomas D. CareyIndependent Non-Employee Chairman of the Board
- HKHanjoon KimChief Financial Officer
- SMSean MackaySenior VP & Chief Business Officer
- JMJonathan MickelsenVP & Chief Accounting Officer
- JGJohn GrazianoVice President of Investor Relations
- FMFenel M. EloiIndependent Non-Employee Director
- EDEli Decatur CasdinIndependent Non-Employee Director
- 公司名稱Alamar Biosciences, Inc.股票代碼ALMR職務Lead Independent Director共事同僚
- YLYuling LuoCo-Founder, Chairman & CEO
- SCShiping ChenCo-Founder, COO & Director
- JJJustin J. McAnearChief Financial Officer
- TOTimothy Ogden WhitePresident
- YYYiyuan YinCo-Founder, VP of Technology & Acting Secretary
- RCRebecca ChambersIndependent Director
- FRFranklin R. WitneyLead Independent Director
- NJNicholas J. NaclerioIndependent Director
